SCHEMBL14043300

SCHEMBL14043300

Cc1cc(-c2ccco2)nc2c(Br)cnn12

nearest known ligand 0.55

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ GSK3B P49841 2/20 0.55
▸ KDM4E B2RXH2 10/20 0.46
▸ TDP1 Q9NUW8 3/20 0.46
▸ ALDH1A1 P00352 11/20 0.44
▸ HPGD P15428 7/20 0.44
▸ HSD17B10 Q99714 6/20 0.44
▸ GAA P10253 4/20 0.44
▸ CASP1 P29466 4/20 0.44
▸ CASP7 P55210 4/20 0.44
▸ MAPT P10636 3/20 0.44
▸ GLA P06280 2/20 0.44
▸ MEN1 O00255 3/20 0.44
▸ KMT2A Q03164 3/20 0.44
▸ POLB P06746 3/20 0.44
▸ ESR1 P03372 1/20 0.44
▸ ESR2 Q92731 1/20 0.44
▸ CHEK1 O14757 1/20 0.43
▸ CCNA2 P20248 1/20 0.43
▸ CDK2 P24941 1/20 0.43
▸ CCNA1 P78396 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL12953212 0.84 GSK3B (0.58) GSK3BKDM4ETDP1ALDH1A1HPGD
SCHEMBL13993127 0.84 CHEK1 (0.63) GSK3BKDM4ETDP1ALDH1A1HPGD
SCHEMBL6030811 0.81 KDM4E (0.69) GSK3BKDM4ETDP1ALDH1A1HPGD
SCHEMBL7832884 0.80 GSK3B (0.50) GSK3BKDM4ETDP1ALDH1A1HPGD
SCHEMBL7835695 0.80 GSK3B (0.48) GSK3BKDM4ETDP1ALDH1A1HPGD
SCHEMBL7832777 0.78 GSK3B (0.50) GSK3BKDM4ETDP1ALDH1A1HPGD
SCHEMBL14492452 0.77 CDK2 (0.69) GSK3BKDM4EALDH1A1HPGDHSD17B10
SCHEMBL13998534 0.77 GSK3B (0.65) GSK3BKDM4ETDP1ALDH1A1HPGD
SCHEMBL14043298 0.76 CDK2 (0.46) GSK3BKDM4EALDH1A1HPGDHSD17B10
SCHEMBL7833824 0.75 GSK3B (0.55) GSK3BKDM4ETDP1ALDH1A1HPGD

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2008130570-A1 NOVEL PYRAZOLOPYRIMIDINES AS CYCLIN DEPENDENT KINASE INHIBITORS SCHERING CORPORATION (US) 2008-10-30 — — WO disclosed
WO-2008130569-A1 NOVEL PYRAZOLOPYRIMIDINES AS CYCLIN DEPENDENT KINASE INHIBITORS SCHERING CORPORATION (US) 2008-10-30 — — WO disclosed
WO-2007044401-A2 NOVEL PYRAZOLOPYRIMIDINES AS CYCLIN DEPENDENT KINASE INHIBITORS SCHERING CORPORATION (US) 2007-04-19 — — WO disclosed
WO-2007044420-A1 PYRAZOLOPYRIMIDINES AS CYCLIN DEPENDENT KINASE INHIBITORS FOR THE TREATMENT OF CANCER SCHERING CORPORATION (US) 2007-04-19 — — WO disclosed
WO-2007044449-A2 NOVEL PYRAZOLOPYRIMIDINES AS CYCLIN DEPENDENT KINASE INHIBITORS SCHERING CORPORATION (US) 2007-04-19 — — WO disclosed
Send feedback